Goldwind Science&Technology Co., Ltd. Just Missed EPS By 26%: Here's What Analysts Think Will Happen Next

The analysts might have been a bit too bullish on Goldwind Science&Technology Co., Ltd. (SZSE:002202), given that the company fell short of expectations when it released its full-year results last week. Results showed a clear earnings miss, with CN¥57b revenue coming in 2.1% lower than what the analystsexpected. Statutory earnings per share (EPS) of CN¥0.42 missed the mark badly, arriving some 26% below what was expected. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Goldwind Science&Technology after the latest results.

Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit.

After the latest results, the 14 analysts covering Goldwind Science&Technology are now predicting revenues of CN¥70.9b in 2025. If met, this would reflect a sizeable 25% improvement in revenue compared to the last 12 months. Per-share earnings are expected to bounce 60% to CN¥0.68. Yet prior to the latest earnings, the analysts had been anticipated revenues of CN¥67.1b and earnings per share (EPS) of CN¥0.76 in 2025. So it's pretty clear the analysts have mixed opinions on Goldwind Science&Technology after the latest results; even though they upped their revenue numbers, it came at the cost of a real cut to per-share earnings expectations.

View our latest analysis for Goldwind Science&Technology

The consensus price target was unchanged at CN¥11.42, suggesting the business is performing roughly in line with expectations, despite some adjustments to profit and revenue forecasts. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. There are some variant perceptions on Goldwind Science&Technology, with the most bullish analyst valuing it at CN¥15.70 and the most bearish at CN¥9.00 per share. As you can see, analysts are not all in agreement on the stock's future, but the range of estimates is still reasonably narrow, which could suggest that the outcome is not totally unpredictable.

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. The analysts are definitely expecting Goldwind Science&Technology's growth to accelerate, with the forecast 25% annualised growth to the end of 2025 ranking favourably alongside historical growth of 3.1% per annum over the past five years. Compare this with other companies in the same industry, which are forecast to grow their revenue 17% annually. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect Goldwind Science&Technology to grow faster than the wider industry.

The Bottom Line

The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. Happily, they also upgraded their revenue estimates, and are forecasting them to grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. We have estimates - from multiple Goldwind Science&Technology analysts - going out to 2027, and you can see them free on our platform here.

You should always think about risks though. Case in point, we've spotted 3 warning signs for Goldwind Science&Technology you should be aware of, and 1 of them can't be ignored.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.